MDGL
Madrigal Pharmaceuticals, Inc. · Healthcare · Biotechnology
动量输入（同类管理人）：
持有人广度 +8.3% ·
股份流向 +5.9% ·
净新建仓位 +7.7%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 28.27K | $13.62M | n/a | n/a |
| Q2 2026 | 121 | +1 | 10.47M | $5.62B | +9 | −9 |
| Q1 2026 | 124 | +7 | 12.07M | $6.32B | +9 | −3 |
| Q4 2025 | 116 | 0 | 12.47M | $7.26B | +1 | n/a |
| Q3 2025 | 19 | +1 | 6.80M | $3.12B | +1 | −1 |
| Q2 2025 | 16 | 0 | 6.45M | $1.95B | n/a | n/a |
| Q1 2025 | 13 | +1 | 2.28M | $753.61M | +1 | n/a |
| Q4 2024 | 12 | +2 | 2.15M | $662.73M | +2 | n/a |
| Q3 2024 | 9 | +1 | 1.41M | $299.66M | +3 | −2 |
| Q2 2024 | 8 | n/a | 1.43M | $401.79M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 758.51K | -2.9% | $251.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 542.63K | -7.8% | $179.74M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (被动) | 420.88K | +2.5% | $139.44M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Adage Capital Partners ✦ | 191.61K | +860.0% | $63.47M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 99.01K | +315.2% | $32.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (被动) | 94.00K | -18.3% | $31.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 85.09K | -47.1% | $28.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 65.86K | 新增 | $21.81M | 0.1% | New | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 10 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 11 | Marshall Wace ✦ | 2.80K | -84.0% | $927,444 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Millennium Management ✦ | 2.51K | +90.8% | $830,394 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 801 | -94.6% | $265,315 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $21.81M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 374 持有人, 23.71M 股份, $12.08B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 120 股 · $65,565
Officer, Director · 60 股 · $31,985
Officer, Director · 106 股 · $56,611
Officer, Director · 218 股 · $116,836
Officer, Director · 160 股 · $86,019
Officer, Director · 687 股 · $371,382
Officer, Director · 368 股 · $199,324
Officer, Director · 1.20K 股 · $652,209
Officer, Director · 1.54K 股 · $837,253
Officer, Director · 761 股 · $414,616
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论